Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study

Brand, Randall E.; Persson, Jan; Bratlie, Svein Olav; Chung, Daniel C.; Katona, Bryson W.; Carrato, Alfredo; Castillo, María Encarnación; Earl, Julie; Kokkola, Arto; Lucas, Aimee L.; Moser, A. James; DeCicco, Corinne; Dexlin Mellby, Linda; King, Thomas C

APA

Brand, Randall E. & Persson, Jan & Bratlie, Svein Olav & Chung, Daniel C. & Katona, Bryson W. & Carrato, Alfredo & Castillo, María Encarnación & Earl, Julie & Kokkola, Arto & Lucas, Aimee L. & Moser, A. James & DeCicco, Corinne & Dexlin Mellby, Linda & King, Thomas C (2022-02 ) .Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study.

ISO 690

Brand, Randall E. & Persson, Jan & Bratlie, Svein Olav & Chung, Daniel C. & Katona, Bryson W. & Carrato, Alfredo & Castillo, María Encarnación & Earl, Julie & Kokkola, Arto & Lucas, Aimee L. & Moser, A. James & DeCicco, Corinne & Dexlin Mellby, Linda & King, Thomas C. 2022-02 .Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study.

https://hdl.handle.net/20.500.12080/39553

EndNote

Mendeley

dc.contributor.author	Brand, Randall E.
dc.contributor.author	Persson, Jan
dc.contributor.author	Bratlie, Svein Olav
dc.contributor.author	Chung, Daniel C.
dc.contributor.author	Katona, Bryson W.
dc.contributor.author	Carrato, Alfredo
dc.contributor.author	Castillo, María Encarnación
dc.contributor.author	Earl, Julie
dc.contributor.author	Kokkola, Arto
dc.contributor.author	Lucas, Aimee L.
dc.contributor.author	Moser, A. James
dc.contributor.author	DeCicco, Corinne
dc.contributor.author	Dexlin Mellby, Linda
dc.contributor.author	King, Thomas C
dc.date.accessioned	2024-02-07T14:48:56Z
dc.date.available	2024-02-07T14:48:56Z
dc.date.created	2022-02
dc.date.issued	2022-02
dc.identifier.uri	https://hdl.handle.net/20.500.12080/39553
dc.description.abstract	The IMMray PanCan-d test combines an 8-plex biomarker signature with CA19-9 in a proprietary algorithm to detect pancreatic ductal adenocarcinoma (PDAC) in serum samples. This study aimed to validate the clinical performance of the IMMray PanCan-d test and to better understand test performance in Lewis-null (le/le) individuals who cannot express CA19-9.	es_ES
dc.format	application/pdf	es_ES
dc.language	eng	es_ES
dc.rights	CC-BY	es_ES
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/deed.es	es_ES
dc.title	Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study	es_ES
dc.type	info:eu-repo/semantics/article	es_ES
dc.rights.accessrights	info:eu-repo/semantics/openAccess	es_ES
dc.identifier.location	N/A	es_ES